Back to Ovarian Cancer
This trial is complete. It is no longer accepting participants. Results may be available on ClinicalTrials.gov.

NCT01466049

NCT01466049
Completed Not Applicable

Who may be able to join

Who might be able to join this trial:

  • You are female and 18 years of age or older
  • You have a growth or lump near your ovaries or fallopian tubes that has been confirmed by a scan or imaging test
  • You are already scheduled to have surgery because of this growth or lump
  • You are willing and able to agree to take part by signing a consent form

Who may not be able to join:

  • You have previously been diagnosed with ovarian cancer
  • You have previously had both ovaries surgically removed
  • You are currently pregnant
  • You are unable to agree to take part or sign a consent form for any reason

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

Trial details

Status
Completed
Phase
Not Applicable
Sponsor
Fujirebio Diagnostics, Inc.
Registry
clinicaltrials_gov
Start date
1 December 2011
Est. completion
1 March 2014

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Evaluate novel biomarkers for patients with an adnexal mass

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

View original record on ClinicalTrials.gov